Drug combination sidesteps resistance in aggressive childhood neuroblastoma models

A discovery from Australian researchers could lead to better treatment for children with neuroblastoma, a cancer that currently claims 9 out of 10 young patients who experience recurrence. The team at the Garvan Institute of Medical Research in Sydney, Australia, found a drug combination that can bypass the cellular defenses these tumors develop that lead to relapse.

Read more: https://medicalxpress.com/news/2025-11-drug-combination-sidesteps-resistance-aggressive.html